NASDAQ : MASS
908 Devices Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 11.25 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 465.00M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 465.00M |
| Enterprise Value | 367.77M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 41.33M |
| Shares Outstanding | 41.33M |
| Shares Change (YoY) | +4.32% |
| Shares Change (QoQ) | +2.47% |
| Owned by Insiders (%) | 7.59% |
| Owned by Institutions (%) | 58.72% |
| Float | 28.07M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.64 |
| Forward PS | 6.14 |
| PB Ratio | 3.38 |
| P/TBV Ratio | 6.59 |
| P/FCF Ratio | 756.10 |
| P/OCF Ratio | 311.87 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 6.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 598.00 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.67 |
| Quick Ratio | 2.29 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | 6.99 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -24.95% |
| Return on Assets (ROA) | -6.81% |
| Return on Invested Capital (ROIC) | -9.32% |
| Return on Capital Employed (ROCE) | -14.31% |
| Weighted Average Cost of Capital (WACC) | 7.62% |
| Revenue Per Employee | $353,721 |
| Profits Per Employee | -$201,494 |
| Employee Count | 172 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.93 |
Taxes
| Measure | Value |
|---|
| Income Tax | -191,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +46.29% |
| 50-Day Moving Average | 11.22 |
| 200-Day Moving Average | 8.37 |
| Relative Strength Index (RSI) | 45.77 |
| Average Volume (20 Days) | 361,177 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.71M |
| Short Previous Month | 2.73M |
| Short % of Shares Out | 6.55% |
| Short % of Float | 9.65% |
| Short Ratio (days to cover) | 6.78 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 60.84M |
| Gross Profit | 32.03M |
| Operating Income | -21.20M |
| Pretax Income | -34.57M |
| Net Income | -34.66M |
| EBITDA | -16.49M |
| EBIT | -21.20M |
| Loss Per Share | -$0.94 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 101.53M |
| Total Debt | 4.30M |
| Net Cash | 97.23M |
| Net Cash Per Share | $2.35 |
| Equity (Book Value) | 126.77M |
| Book Value Per Share | 3.33 |
| Working Capital | 82.60M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.49M |
| Capital Expenditures | -876,000 |
| Depreciation & Amortization | 4.70M |
| Net Borrowing | n/a |
| Free Cash Flow | 615,000 |
| FCF Per Share | $0.01 |
Margins
| Measure | Value |
|---|
| Gross Margin | 52.65% |
| Operating Margin | -34.84% |
| Pretax Margin | -56.82% |
| Profit Margin | -56.96% |
| EBITDA Margin | -27.11% |
| EBIT Margin | -34.84% |
| FCF Margin | 1.01% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.32% |
| Shareholder Yield | -4.32% |
| Earnings Yield | -8.39% |
| FCF Yield | 0.13% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $13.38 |
| Price Target Difference | 18.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 20.18% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.84 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |